Naoto Ueno, Director of the University of Hawaii Cancer Center, shared on LinkedIn:
”I was pleased to share my perspectives with ‘Cancer Drug Resistance’ on ADC resistance and the future of cancer therapy.
We discussed how tumor evolution and the tumor microenvironment influence treatment resistance, and how emerging approaches – including next-generation ADCs, rational combinations, and new translational models – may help us stay ahead of resistance.
Our goal is simple: understand resistance so we can design better treatments for our patients.”
Naoto Ueno was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles featuring Naoto Ueno on OncoDaily.